What is APRIL (A Proliferation-Inducing Ligand)?
APRIL is a tumor necrosis factor (TNF) superfamily cytokine that plays a critical role in B-cell survival, plasma cell maintenance, and immunoglobulin production by binding to receptors BCMA and TACI on B cells.
Molecular Identity and Structure
APRIL (A Proliferation-Inducing Ligand, also known as TALL-2 or TRDL-1) is a secreted member of the TNF ligand superfamily 1. It is predominantly produced by myeloid cells, including monocytes and dendritic cells 2, 3.
Receptor Binding and Signaling
APRIL functions through binding to two distinct TNF receptor superfamily members:
- BCMA (B-cell maturation antigen) - expressed on mature B cells and plasma cells
- TACI (transmembrane activator and calcium modulator and cyclophilin ligand interactor) - also expressed on B cells
Additionally, APRIL binds to heparan sulfate proteoglycans (HSPGs), though the physiological significance of this interaction remains incompletely understood 4. APRIL competes with another TNF family member, TALL-I (also called BLyS or BAFF), for binding to these same receptors 1.
Key Functions in B-Cell Biology
Plasma Cell Survival and Maintenance
The most critical function of APRIL is maintaining long-lived plasma cells and sustaining immunoglobulin production throughout life 2. Evidence from the first reported case of complete APRIL deficiency in humans revealed that APRIL is essential for lifelong plasmacyte maintenance - the patient exhibited hypogammaglobulinemia with markedly reduced plasma cells in peripheral blood 2.
B-Cell Proliferation and Differentiation
APRIL sustains the proliferation of both naïve (CD27⁻) and memory B cells 3, 1. It induces differentiation of:
- Memory B cells into plasma cells 2
- Naïve human B cells into long-lived plasma cells in vitro via BCMA and TACI signaling 3
Humoral Immunity
Blocking APRIL signaling with soluble BCMA-Fc inhibits antibody production against antigens in mice, demonstrating that APRIL signaling through BCMA and/or TACI is required for generating humoral immunity 1.
Specialized Niche Function
Plasma B cells survive in a specialized APRIL-rich niche, where local APRIL concentrations support their long-term survival 4.
Clinical Relevance
Role in Autoimmunity
In chronic lymphocytic leukemia (CLL), tumor cells can act as antigen-presenting cells and induce formation of autoreactive T-helper cells through production of B-cell-activating factor and APRIL 5. This contributes to the autoimmune complications observed in CLL patients.
Malignancy Associations
APRIL was initially identified as overexpressed in tumor tissues 6. Aberrant APRIL expression and subsequent activation of pro-survival pathways may drive survival of several B-cell malignancies, making it an important therapeutic target 4, 6.
Diagnostic Applications
APRIL mRNA and protein detection in sputum has shown promise as a biomarker for lung cancer detection, with reported sensitivity of 82% and specificity of 97% for mRNA amplification, and good discrimination between cases and controls for protein measurement 7.
Mechanism Summary
APRIL's mechanism centers on providing survival signals to plasma cells through BCMA and TACI receptors, activating pro-survival pathways that maintain antibody-secreting cells in bone marrow and other lymphoid tissues. Without functional APRIL, as demonstrated in human deficiency, plasma cell populations collapse and immunoglobulin production fails 2.